EYPT

EyePoint Pharmaceuticals Inc.

Price

$6.30

return (12m)

-42.93%

p/e

-3.94

p/bv

7.26

DIVIDEND YIELD

0.00%

EYPT price

EyePoint Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EYPT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-51.76%

3 months

-50.70%

1 year

-42.93%

2 years

-20.65%

5 years

-37.62%

10 years

-84.33%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals EYPT

Valuation

P/E

-3.94

Sector -2.19

Industry 1.21

P/BV

7.26

Sector 2.22

Industry 2.11

P/Revenue (PSR)

431.27

Sector 2.01

Industry 0.78

EV/EBITDA

-10.62

Sector -17.81

Industry -25.30

EV/EBIT

-10.55

Sector -26.72

Industry -18.04

P/EBITDA

-3.99

Sector 0.36

Industry 0.18

P/EBIT

-3.96

Sector -3.34

Industry 1.26

P/Total Assets

5.29

Sector 1.23

Industry 0.86

P/Net Current Assets

9.51

Sector -27.35

Industry -12.37

P/Working Capital

8.22

Sector -4.54

Industry -49.48

EPS

-3.52

Sector -0.87

Industry -0.55

BVPS

1.91

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

41.43%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-18,958.82%

Sector -323.65%

Industry -73.39%

EBIT Margin

-19,094.12%

Sector -194.57%

Industry -11.94%

Operating Margin

-100.00%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-100.00%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.00

Sector 0.12

Industry 0.22

Profitability

ROE

-184.27%

Sector -33.82%

Industry -37.56%

ROA

-134.38%

Sector -29.63%

Industry -17.56%

ROIC

-780.08%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.50

Sector 1.84

Industry 1.14

Net Debt / EBITDA

1.87

Sector -1.47

Industry -31.86

Net Debt / EBIT

1.85

Sector -1.32

Industry 2.06

Net Debt / Equity

-1.08

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.73

Sector 0.42

Industry 0.25

Liabilities/Assets

0.27

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

-40.30%

Sector -

Industry -

5Y Earnings CAGR

39.32%

Sector -

Industry -

Fundamentals EYPT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EYPT EyePoint Pharmaceuticals Inc.	$6.30	-44.40%	0.00%	-3.94	7.26	-184.27%	-100.00%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EYPT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2008

Time since IPO - 18 years

84

Employees

EyePoint Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.21 billion, with shareholders equity totaling $166.41 million.

The company employs approximately 84 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, EyePoint Pharmaceuticals Inc. reported $2.80 million in revenue, generating net income of $-306.64 million.

Key financial metrics include a P/E ratio of -3.94, a price-to-book (P/B) ratio of 7.26, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EYPT.

Market cap

$1.21 billion

Net worth

$166.41 million

$166,410,000.00

Assets

$228.19 million

$228,190,000.00

Total Shares Outstanding

87.00 million

87,000,000

Average Daily Trading Volume

$1.59 million

$1,587,560.00

Sector

Health

Industry

Pharmaceutical Products

EYPT

EYPT revenue and profits

Financial Results EYPT

DRAG THE FRAME TO SEE MORE DATA

EYPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87